Oral Entrainment on Suck Development of Preterm Infants Born 23 to 34 Weeks Gestational Age (GA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01069744 |
Recruitment Status :
Completed
First Posted : February 17, 2010
Last Update Posted : February 17, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Preterm Birth |

Study Type : | Observational |
Actual Enrollment : | 71 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Randomized Control Trial Evaluating The Effect Of Patterned Oral Somatosensory Entrainment Stimulation Program (NTrainer System) On Suck Development and Feeding Performance of Preterm Infants Born Between 23 And 34 Weeks Gestational Age |
Study Start Date : | November 2007 |
Actual Primary Completion Date : | November 2008 |
Actual Study Completion Date : | November 2008 |
Group/Cohort |
---|
Control Group
Control group When neonates are considered ready for oral feedings these feedings will be started with the standard oral feeding protocol for the NICU but without the NTrainer stimulation regimen described previously.
|
NTrainer System
NTrainer Experimental Group When neonates are considered ready for oral feedings these feedings will be started simultaneously with the NTrainer therapy. Control and experimental interventions will not be initiated until the infant is in an optimal behavioral state, i.e., drowsy to quiet alert (NIDCAP state 3 or 4). Preterm infants in the experimental group will receive alternating 3-minute epochs of patterned oral somatosensory stimulation and null conditions using the NTrainer© during the tube (gavage) feeding session up to 4 times per day.
|
- The Non-Nutritive Suck SpatioTemporal Index (NNS STI) [ Time Frame: 28 days ]
- Transition-to-Oral Feed (TOF) [ Time Frame: 28 days ]
- Length-of-Stay (LOS) in the NICU [ Time Frame: 28 days ]
- Growth velocity: Weight Gain (gms/kg/day) [ Time Frame: 28 days ]
- Growth velocity: Head Growth (cm/wk) [ Time Frame: 28 days ]
- Growth velocity: Length Growth (cm/wk) [ Time Frame: 28 days ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 23 Weeks to 34 Weeks (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Estational age between 23 weeks and 0/7 days and 34 weeks as per the best estimate by the neonatologist.
- No major anomalies (chromosomal abnormalities, cyanotic congenital heart disease, gastroschisis, omphalocele, diaphragmatic hernia or other major gastrointestinal anomalies, major neurological injury or anomaly, and multiple congenital anomalies)
- Ready for oral feedings. Neonates who meet eligibility criteria (A-E) will be assessed by the health care team (neonatology and occupational therapist) with the NTrainer beginning at 32 weeks post menstrual age A. Hemodynamically stable and off all vasopressors B. Tolerating 120 ml/kg/day of enteral feedings C. Respiratory rate <80 breaths per minute D. Alert and active neurologic exam appropriate for post-menstrual age E. No signs of sepsis or intolerance of gastric feedings
Exclusion Criteria:
- Gestational age < 23 weeks or > 34 weeks
- Any major congenital anomalies
- Not ready for oral feedings

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01069744
United States, Kansas | |
Overland Park Regional Medical Center | |
Overland Park, Kansas, United States, 66215 |
Principal Investigator: | Steven M Barlow, Ph.D. | University of Kansas |
Responsible Party: | Steven M. Barlow, PhD, Professor, SPLH, Neuroscience, Human Biology, and Bioengineering,Communication Neuroscience Laboratories, Uninversity of Kansas |
ClinicalTrials.gov Identifier: | NCT01069744 |
Other Study ID Numbers: |
oprmc1 |
First Posted: | February 17, 2010 Key Record Dates |
Last Update Posted: | February 17, 2010 |
Last Verified: | February 2010 |
Premature Birth Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications |